News of the Day

New Zealand's Medsafe and Pharmac will make changes in early 2026 to enable general practitioners (GPs) and nurse practitioners to initiate treatment for adults with ADHD.

Ovarian Cancer diagnostics company, Cleo Diagnostics (ASX:COV), has received formal approval from the US National Cancer Institute to access blood samples held within the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial biobank.

The Leukaemia Foundation is marking Rare Cancers Awareness Day by calling for greater awareness and urgent investment in research to tackle one of the deadliest and underinvested rare cancers in Australia.

Rare Cancers Australia CEO Christine Cockburn added, “These results offer real hope to people living with soft tissue sarcoma and other rare cancers, who too often face limited treatment options and poor outcomes."

Noxopharm (ASX:NOX) has announced that recruitment activities are progressing rapidly and on schedule for the HERACLES clinical trial.

The spike in cases in the territory reflects a recent national trend. Australia recorded over 57,000 cases of whooping cough in 2024, the most ever recorded in a single year since records began, and 14,000 registered this year.

AusBiotech has wrapped a significant week of bilateral and multilateral engagements at the BIO International Convention 2025 (BIO25) in Boston.

Asked to clarify whether yesterday's reference to access to high-quality medicines "quickly", and whether it reflected a shift from his previously stated concerns over access delays, a spokesperson for the minister said it was specific to TRIKAFTA.

In response to the report, PhRMA said Australia, Canada, Korea and the UK "allow bureaucrats to devalue human life to justify ultra-low drug prices."

FivepHusion has announced the successful completion of the Phase 1 component of the Deflexifol at Relapse Trial, supported by the Kids with Cancer Foundation, an Australian-led study of a new brain cancer treatment for children.

Noel Carmona began urgent treatment. With 12 rounds of immunotherapy costing over $60,000, which the PBS did not reimburse, he was forced to fundraise and access his wife’s superannuation to afford care.

A new survey commissioned by heart charity Hearts4heart and conducted by YouGov indicates more than five million Australians are not aware of the common comorbidities linked to heart failure, such as kidney disease, type 2 diabetes, cancer, lung disease and sleep-disordered breathing.